Crossmark

Clinical pathway of metabolic therapy with 131I in differentiated thyroid cancer

Crossref DOI link: https://doi.org/10.1016/j.remnie.2023.03.001

Published Print: 2023-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Blanco Saiz, I.

Anda Apiñániz, E.

Pineda Arribas, J.

Caudepón Moreno, F.

Fernández Iglesias, A.

Huarte Jiménez, M.

de Miguel Muñoz, A.I.

Irigoyen Aristorena, M.I.

Goñi Gironés, E.
License Information

Text and Data Mining valid from 2023-05-01
More Information

This article is maintained by: Elsevier

Article Title: Clinical pathway of metabolic therapy with 131I in differentiated thyroid cancer

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2023.03.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2023.02.002

Content Type: article

Copyright: © 2023 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.